Literature DB >> 7698512

Plasma endothelin-1 levels in obese hypertensive and normotensive men.

C Ferri1, C Bellini, G Desideri, L Di Francesco, R Baldoncini, A Santucci, G De Mattia.   

Abstract

Plasma endothelin-1 (ET-1) levels were studied in 15 obese hypertensive (mean age 48.5 +/- 3.9 years) and 15 obese normotensive men (mean age 49.5 +/- 3.6 years) before and after weight loss due to an 800 kcal/day diet lasting 12 weeks. Circulating peptide concentrations were also assessed in nonobese hypertensive (n = 11) and normotensive men (n = 12). Baseline plasma ET-1 levels were similar in obese hypertensive (0.87 +/- 0.22 pg/ml) and obese normotensive men (0.91 +/- 0.30 pg/ml). In seven obese hypertensive men, caloric restriction normalized blood pressure levels (systolic: from 166.6 +/- 8.1 to 145.0 +/- 6.3 mmHg, P < 0.0001; diastolic: from 106.6 +/- 5.1 to 89.1 +/- 2.0 mmHg, P < 0.0001) and decreased body mass index (BMI) (from 33.4 +/- 1.6 to 29.6 +/- 2.1 kg/m2, P < 0.002) and plasma ET-1 levels (from 0.93 +/- 0.21 to 0.64 +/- 0.26 pg/ml, P < 0.05). In the remaining obese hypertensive men (n = 8), blood pressure levels were not normalized by caloric restriction despite a significant decrease of BMI and plasma ET-1 levels (from 0.83 +/- 0.23 to 0.60 +/- 0.16 pg/ml, P < 0.04). Weight loss also significantly decreased BMI and ET-1 (from 0.91 +/- 0.30 to 0.65 +/- 0.19 pg/ml, P < 0.01) in obese normotensive men. Baseline ET-1 and fasting insulin levels were significantly correlated in obese hypertensive (r = 0.518, P < 0.05) and obese normotensive men (r = 0.535, P < 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7698512     DOI: 10.2337/diab.44.4.431

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Endothelin-1 response to glucose and insulin among African Americans.

Authors:  Stephanie DeLoach; Yonghong Huan; Constantine Daskalakis; Bonita Falkner
Journal:  J Am Soc Hypertens       Date:  2010-08-21

2.  Acute blockade by endothelin-1 of haemodynamic insulin action in rats.

Authors:  R M Ross; C M Kolka; S Rattigan; M G Clark
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Coronary microvascular dysfunction in diabetes mellitus: A review.

Authors:  Andrea Picchi; Stefano Capobianco; Tianyi Qiu; Marta Focardi; Xiaoqin Zou; Ji-Min Cao; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-11-26

Review 5.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

6.  Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism.

Authors:  Andrew B Strawbridge; Jeffrey S Elmendorf
Journal:  J Cell Biochem       Date:  2006-03-01       Impact factor: 4.429

7.  Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea.

Authors:  Pierluigi Carratù; Valentina Anna Ventura; Mauro Maniscalco; Silvano Dragonieri; Simona Berardi; Roberto Ria; Vitaliano Nicola Quaranta; Angelo Vacca; Fiorella Devito; Marco Matteo Ciccone; Barbara Anne Phillips; Onofrio Resta
Journal:  Sleep Breath       Date:  2015-09-18       Impact factor: 2.816

8.  Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Authors:  Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 9.  Mechanisms of endothelial dysfunction in the metabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

10.  Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.

Authors:  Mostafa M Elgebaly; Aisha Kelly; Alex K Harris; Hazem Elewa; Vera Portik-Dobos; Pimonrat Ketsawatsomkron; Mario Marrero; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.